Home / Denial reasons

Denial reasons, decoded

Denial letters are written to end conversations. Each reason below has a meaning, a motive, and a counter-strategy.

How each reason holds up under review

Across 42,749 published external-review decisions, independent physicians overturned the insurer 52.5% of the time — but the odds move with the reason on the letter.

Medical Necessity
55.1%
overturned of 31,504 decisions. The most common reason, and the most winnable — these fights turn on your doctor's documentation.
Experimental/Investigational
45.3%
overturned of 10,476 decisions. Turns on published evidence. Appeals that cite studies and guidelines do the arguing.
Urgent Care
42.3%
overturned of 769 decisions. Expedited external reviews, decided in days. Fewer of them, and harder — but far from hopeless.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · CALIFORNIA DECISIONS · METHODOLOGY

Featured guide
GLP-1 & weight-loss drug denials — Wegovy, Zepbound, Ozempic, MounjaroThe most-denied drug class in America, and the published record on how appeals turn out. Cross-indication strategy, step-therapy exceptions, and the numbers drug by drug.
Featured guide
Crohn’s & colitis biologic denials — Humira, Skyrizi, Stelara, Entyvio, Remicade, RinvoqStep therapy, biosimilar switching, dose caps — the denial machine around IBD biologics, and the published record on how appeals turn out, drug by drug.
Featured guide
Migraine, CGRP drug & Botox denials — Ajovy, Emgality, Aimovig, gepantsA deduplicated 993-decision evidence graph, the clinical lanes plans commonly mix up, and the record needed for step therapy, Botox, and reauthorization appeals.
Featured guide
Behavioral-health level-of-care denials — residential, PHP, IOP, inpatient & withdrawal management3,843 distinct California review decisions, the admission and continued-stay evidence reviewers can test, and a parity lane that keeps TMS in its own procedure-specific denominator.
Denied as “not medically necessary”The insurer's reviewer decided your treatment doesn't meet their internal criteria for being needed — often without examining you,Denied as “experimental or investigational”The insurer claims the treatment isn't proven — that it's still research-stage medicine and therefore excluded by your plan.Prior authorization denied or missingEither the plan refused advance approval for a service, or care already happened without the approval paperwork and the claim was Denied as out-of-networkThe insurer says the provider who treated you isn't in your plan's network, so it's paying less or nothing.Denied as “not a covered benefit”The insurer says your plan simply doesn't include this service, no matter how necessary it is.Denied for coding or billing problemsThe claim was rejected over paperwork: wrong CPT code, missing modifier, mismatched diagnosis, duplicate claim, or a timely-filingPrescription drug denied — formulary, step therapy, or quantity limitsThe pharmacy benefit refused your medication: it's not on the plan's formulary, the plan wants you to fail a cheaper drug first (s